Patents by Inventor Simon Fraser

Simon Fraser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9418171
    Abstract: Systems and methods for hardware accelerated presentation of web pages on mobile computing devices are presented. A plurality of web pages may be received by a computing device capable of processing and displaying web pages using layout engines, hardware accelerated graphics application programming interfaces (APIs). Upon receipt of the web pages, the web pages may be divided into a plurality of rendering layers, based upon stylesheets of the web pages. An algorithm walks through rendering layers so as to select a plurality of layers that may receive compositing layers so as to take advantage of hardware acceleration when rendered. The web pages may be subsequently presented on a display of the mobile computing devices using remaining rendering layers and compositing layers. In this manner, visual representation of web content remains intact even when content which may not have been originally designed for use with layout engine may be displayed.
    Type: Grant
    Filed: March 3, 2009
    Date of Patent: August 16, 2016
    Assignee: Apple Inc.
    Inventor: Simon Fraser
  • Patent number: 9359352
    Abstract: The present invention provides substituted benzimidazole compounds of Formula I: wherein the variables R1, R2, W1, W2, W3, W4, W5, W6, Wa, Wb, Wc and Wd are defined herein. The compounds are useful as phosphoinositide 3-kinase (PI3 kinase) inhibitors.
    Type: Grant
    Filed: July 16, 2015
    Date of Patent: June 7, 2016
    Assignee: Intellikine LLC
    Inventors: Pingda Ren, Yi Liu, Liansheng Li, Katrina Chan, Troy Edward Wilson, Simon Fraser Campbell
  • Publication number: 20150320727
    Abstract: Heterocyclic entities that modulate PI3 kinase activity, pharmaceutical compositions containing the heterocyclic entities, and methods of using these chemical entities for treating diseases and conditions associated with PI3 kinase activity are described herein.
    Type: Application
    Filed: June 2, 2015
    Publication date: November 12, 2015
    Inventors: Pingda Ren, Yi Liu, Liansheng Li, Katrina Chan, Troy Edward Wilson, Simon Fraser Campbell
  • Publication number: 20150322064
    Abstract: Heterocyclic entities that modulate PI3 kinase activity, pharmaceutical compositions containing the heterocyclic entities, and methods of using these chemical entities for treating diseases and conditions associated with PI3 kinase activity are described herein.
    Type: Application
    Filed: July 16, 2015
    Publication date: November 12, 2015
    Inventors: Pingda Ren, Yi Liu, Liansheng Li, Katrina Chan, Troy Edward Wilson, Simon Fraser Campbell
  • Patent number: 9127000
    Abstract: Heterocyclic entities that modulate PI3 kinase activity, pharmaceutical compositions containing the heterocyclic entities, and methods of using these chemical entities for treating diseases and conditions associated with PI3 kinase activity are described herein.
    Type: Grant
    Filed: February 23, 2012
    Date of Patent: September 8, 2015
    Assignee: Intellikine, LLC.
    Inventors: Pingda Ren, Yi Liu, Liansheng Li, Katrina Chan, Troy Edward Wilson, Simon Fraser Campbell
  • Patent number: 9104296
    Abstract: Some embodiments relate to providing an improved progress indicator in a graphical user interface. In addition to conveying a completion status of a task to a user, an improved progress indicator in some embodiments can convey additional information about the task to the user. For example, some embodiments can display a visual cue when a triviality threshold indicating that the task is “substantially complete” is met.
    Type: Grant
    Filed: September 13, 2012
    Date of Patent: August 11, 2015
    Assignee: Apple Inc.
    Inventors: Damian Kaleta, Kevin Decker, Dan Bernstein, Beth Dakin, Simon Fraser, Samuel Weinig, Dave Hyatt, Geoffrey Garen
  • Patent number: 9096590
    Abstract: The present invention provides substituted benzoxazole compounds of the Formula: wherein the variables R1, R2, W1, W2, W3, W4, W5, are W6 are defined herein. The compounds are useful as phosphoinositide 3-kinase (PI3 kinase) inhibitors.
    Type: Grant
    Filed: May 24, 2011
    Date of Patent: August 4, 2015
    Assignee: Intellikine LLC
    Inventors: Pingda Ren, Yi Liu, Liansheng Li, Katrina Chan, Troy Edward Wilson, Simon Fraser Campbell
  • Patent number: 9085560
    Abstract: A method of inhibiting phosphatidyl inositol-3 kinase (PI3 kinase), comprising: contacting the PI3 kinase with an effective amount of a compound or pharmaceutically acceptable salt of the formula below, wherein the variables R1, R2, W1, W2, W3, W4, W5, are W6 are defined herein.
    Type: Grant
    Filed: August 17, 2010
    Date of Patent: July 21, 2015
    Assignee: INTELLIKINE, INC.
    Inventors: Pingda Ren, Yi Liu, Liansheng Li, Katrina Chan, Troy Edward Wilson, Simon Fraser Campbell
  • Publication number: 20150158859
    Abstract: Heterocyclic entities that modulate PI3 kinase activity, pharmaceutical compositions containing the heterocyclic entities, and methods of using these chemical entities for treating diseases and conditions associated with PI3 kinase activity are described herein.
    Type: Application
    Filed: February 23, 2012
    Publication date: June 11, 2015
    Applicant: Intellikine LLC
    Inventors: Pingda Ren, Yi Liu, Liansheng Li, Katrina Chan, Troy Edward Wilson, Simon Fraser Campbell
  • Publication number: 20130261102
    Abstract: Heterocyclic entities that modulate PI3 kinase activity, pharmaceutical compositions containing the heterocyclic entities, and methods of using these chemical entities for treating diseases and conditions associated with PI3 kinase activity are described herein.
    Type: Application
    Filed: May 24, 2011
    Publication date: October 3, 2013
    Inventors: Pingda Ren, Yi Liu, Liansheng Li, Katrina Chan, Troy Edward Wilson, Simon Fraser Campbell
  • Publication number: 20130239039
    Abstract: Some embodiments relate to providing an improved progress indicator in a graphical user interface. In addition to conveying a completion status of a task to a user, an improved progress indicator in some embodiments can convey additional information about the task to the user. For example, some embodiments can display a visual cue when a triviality threshold indicating that the task is “substantially complete” is met.
    Type: Application
    Filed: September 13, 2012
    Publication date: September 12, 2013
    Applicant: Apple Inc.
    Inventors: Damian Kaleta, Kevin Decker, Dan Bernstein, Beth Dakin, Simon Fraser, Samuel Weinig, Dave Hyatt, Geoffrey Garen
  • Publication number: 20130157984
    Abstract: The invention provides in part, conjugate compounds. The invention also provides synthesis methods for making the compounds, and uses of the compounds.
    Type: Application
    Filed: November 28, 2012
    Publication date: June 20, 2013
    Inventor: Simon Fraser University
  • Publication number: 20130131185
    Abstract: The invention provides in part dialkoxybenzene compounds for controlling infestation by a Trichoplusia ni, and methods thereof. The compounds include a compound of Formula I: where R1 may be methyl, ethyl, propyl, n-butyl, isopentyl (3-methylbutyl) or allyl; R2 may be at positions 2, 3 or 4 and may be H, methyl, ethyl, propyl, n-butyl, isopentyl (3-methylbutyl) or allyl; and R3 may be optionally present at positions 2, 3 and 4, and is allyl; except that when R2 is at position 2, R3 if present is at position 3, and when R2 is at position 3, R3 if present is at to positions 2 or 4, and when R2 is at position 4, R3 if present is at position 2, and when R2 is at position 4 and R3, if present, has reacted with an OH group at position 1 in a Markovnikov sense, then R3 becomes R4, a dihydrofuran.
    Type: Application
    Filed: January 4, 2013
    Publication date: May 23, 2013
    Applicants: THE UNIVERSITY OF BRITISH COLUMBIA, SIMON FRASER UNIVERSITY
    Inventors: SIMON FRASER UNIVERSITY, THE UNIVERSITY OF BRITISH COLUMBIA
  • Publication number: 20130035324
    Abstract: Heterocyclic entities that modulate PI3 kinase activity, pharmaceutical compositions containing the heterocyclic entities, and methods of using these chemical entities for treating diseases and conditions associated with PI3 kinase activity are described herein.
    Type: Application
    Filed: August 17, 2010
    Publication date: February 7, 2013
    Inventors: Pingda Ren, Yi Liu, Liansheng Li, Katrina Chan, Troy Edward Wilson, Simon Fraser Campbell
  • Patent number: 8234564
    Abstract: Embodiments of the present invention provide a way to perform transforms and animations using Cascading Style Sheets (CSS). CSS may be used to define colors, fonts, layout, and other aspects of document presentation, such as for a webpage. Embodiments of the present invention provide CSS properties for transforms and animations of document content. New CSS properties for transforms allow for rotation, translation, scaling, skewing, perspective, origin, and the like. CSS properties are also provided for animating document content, such as movement, transitions, and the like.
    Type: Grant
    Filed: March 3, 2009
    Date of Patent: July 31, 2012
    Assignee: Apple Inc.
    Inventors: Gilles Drieu, Simon Fraser, Chris Marrin
  • Publication number: 20120077801
    Abstract: The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a PDE4 mediated disease state.
    Type: Application
    Filed: August 3, 2011
    Publication date: March 29, 2012
    Inventors: Roger Victor Bonnert, Rhona Jane Cox, Simon De Sousa, Mark Dickinson, Simon Fraser Hunt, Austen Pimm, Hitesh Jayantilal Sanganee, Frank Burkamp, Premji Meghani
  • Patent number: 8143261
    Abstract: The invention provides certain thiazolopyrimidine compounds of formula (I) or a pharmaceutically acceptable salt or solvate thereof, processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Grant
    Filed: April 29, 2009
    Date of Patent: March 27, 2012
    Assignee: AstraZeneca AB
    Inventors: Paul Andrew Willis, Roger Bonnert, Simon Fraser Hunt, Iain Alistair Stewart Walters
  • Publication number: 20100204203
    Abstract: The present invention provides a compound of a formula (I), wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a PDE4 mediated disease state.
    Type: Application
    Filed: January 10, 2008
    Publication date: August 12, 2010
    Inventors: Roger Victor Bonnert, Frank Burkamp, Rhona Jane Cox, Simon de Sousa, Mark Dickinson, Simon Fraser Hunt, Premji Meghani, Austen Pimm, Hitesh Jayantilal Sanganee
  • Publication number: 20090281123
    Abstract: The invention provides certain thiazolopyrimidine compounds of formula (I) or a pharmaceutically acceptable salt or solvate thereof, processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Application
    Filed: April 29, 2009
    Publication date: November 12, 2009
    Inventors: Paul Andrew Willis, Roger Victor Bonnert, Simon Fraser Hunt, Iain Alistair Stewart Walters
  • Publication number: 20090233907
    Abstract: The present invention provides a compound of a formula (I): wherein the variables are defined herein; to a process for preparing such a compound; and to the use of such a compound in the treatment of a PDE 4 mediated disease state.
    Type: Application
    Filed: March 20, 2007
    Publication date: September 17, 2009
    Applicant: ASTRAZENECA AB
    Inventors: Rupert Austin, Roger Victor Bonnert, Simon Fraser Hunt, Grigorios Nikitidis, Hitesh Jayantilal Sanganee, Peter Olof Sjo, Dan Warner